ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

DOMINIQUE RUTTEMAN RN, CS

At A Glance: This Prescriber in 2012

Registered Nurse, Psychiatric/Mental Health, Adult

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

4,282Medicare Part D Prescriptions Filled, Including Refills

Rank: 1 out of 19

$376K Total Retail Price of All Prescriptions

Rank: 2 out of 19

362 Patients Receiving at Least One Drug in Part D
91%Patients 65 Years and Older
50% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Massachusetts
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

N/A

Risky Drugs to Seniors

1% of this provider’s 3,659 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 18%.

Prescription Price

$88 was the average price of a prescription from this provider, compared to $103 among peers.

Prescriptions per Patient

12 is the average number of prescriptions (including refills) per patient, compared to an average of 15.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Massachusetts
CITALOPRAM HBR 416 397 1 2
TRAZODONE HCL 340 271 2 1
MIRTAZAPINE 329 315 3 13
DONEPEZIL HCL 313 277 4 19
NAMENDA 256 206 5 22
ESCITALOPRAM OXALATE 207 160 6 26
SERTRALINE HCL 206 206 7 7
GABAPENTIN 203 178 8 20
BUSPIRONE HCL 176 139 9 14
BUPROPION HCL SR 149 130 10 11
RISPERIDONE 141 112 11 6
CYMBALTA 135 125 12 16
OLANZAPINE 126 96 13 10
QUETIAPINE FUMARATE 120 111 14 5
VENLAFAXINE HCL ER 119 108 15 12
ABILIFY 108 87 16 9
GALANTAMINE HBR 106 100 17 31
DIVALPROEX SODIUM 90 76 18 27
FLUOXETINE HCL 83 61 19 3
EXELON 63 40 20 37
DIVALPROEX SODIUM ER 52 31 21 20
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.